Management of liver disease and portal hypertension in common variable immunodeficiency (CVID)Key points
Summary: Patients with common variable immunodeficiency (CVID) frequently develop liver disease and associated complications, which represent an increasingly prevalent unmet medical need. The main hepatic manifestation of CVID is nodular regenerative hyperplasia (NRH), resulting in non-cirrhotic por...
Main Authors: | Lukas S. Baumert, Angela Shih, Raymond T. Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555923002136 |
Similar Items
-
Rituximab and improved nodular regenerative hyperplasia-associated non-cirrhotic liver disease in common variable immunodeficiency: a case report and literature study
by: Willem Roosens, et al.
Published: (2023-09-01) -
A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
by: Michele Fiordaliso, et al.
Published: (2023-10-01) -
Nodular regenerative hyperplasia and liver transplantation: a systematic review
by: Ben E. Biesterveld, et al.
Published: (2023-09-01) -
Portal hypertension in common variable immunodeficiency disorders – a single center analysis on clinical and immunological parameter in 196 patients
by: Leif G. Hanitsch, et al.
Published: (2023-12-01) -
Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease
by: Vanessa Daza-Cajigal, et al.
Published: (2023-06-01)